Lippert William C, Wall Eric J
Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, MLC 2017, Cincinnati, OH 45229, USA.
Pediatrics. 2008 Sep;122(3):e556-63. doi: 10.1542/peds.2008-0374. Epub 2008 Aug 11.
The US Centers for Disease Control and Prevention has needle-length recommendations for intramuscular vaccinations in the thigh and shoulder on the basis of the age of the child. Underpenetration of the intramuscular layer with short needles has been documented; however, few studies have focused on the risk for overpenetration of the intramuscular level with needles that are too long. The purpose of this study was to determine the optimal needle length for intramuscular vaccination of children of various ages and sizes at the shoulder and thigh levels by using MRI and computed tomography scan measurements.
A total of 250 MRI and computed tomography scans of shoulders and thighs of children who were 2 months to 18 years of age at a large children's hospital were reviewed. The thicknesses of the subcutaneous fat tissue and muscle layers were measured. Measurements were correlated with age and weight, and regression analysis was performed.
Use of the Centers for Disease Control and Prevention's recommended 1- and 1 (1/4)-in needles for intramuscular vaccination in the thigh of children >/=1 year of age would result in 11% (11 of 100) and 39% (34 of 88) overpenetration, respectively, with a minimal risk for underpenetration at 2% (2 of 100). Patients with vaccinations in the shoulder with the Centers for Disease Control and Prevention-recommended 58-, 78-, and 1-in needles would experience 11% (16 of 150), 55% (83 of 150), and 61% (92 of 150) overpenetration, respectively.
There is a substantial risk for overpenetration of the intramuscular layer when using current Centers for Disease Control and Prevention recommendations for vaccination needle lengths. We recommend a revision of the needle-length guidelines for thigh and shoulder injections to minimize the risk for needle overpenetration on the basis of the variability observed in the fat thickness.
美国疾病控制与预防中心根据儿童年龄给出了大腿和肩部肌肉注射疫苗的针头长度建议。已有文献记载短针头会导致肌肉层穿透不足;然而,很少有研究关注过长针头导致肌肉层穿透过度的风险。本研究的目的是通过磁共振成像(MRI)和计算机断层扫描测量,确定不同年龄和体型儿童在肩部和大腿部位进行肌肉注射疫苗的最佳针头长度。
回顾了一家大型儿童医院250例2个月至18岁儿童肩部和大腿的MRI及计算机断层扫描图像。测量皮下脂肪组织和肌肉层的厚度。将测量结果与年龄和体重进行关联,并进行回归分析。
对于1岁及以上儿童在大腿进行肌肉注射疫苗,使用疾病控制与预防中心推荐的1英寸和1(1/4)英寸针头,分别会导致11%(100例中的11例)和39%(88例中的34例)的穿透过度,而穿透不足的风险最小,为2%(100例中的2例)。对于在肩部进行疫苗接种的患者,使用疾病控制与预防中心推荐的5/8英寸、7/8英寸和1英寸针头,分别会出现11%(150例中的16例)、55%(150例中的83例)和61%(150例中的92例)的穿透过度。
按照疾病控制与预防中心目前推荐的疫苗接种针头长度,肌肉层穿透过度的风险很大。我们建议修订大腿和肩部注射的针头长度指南,根据观察到的脂肪厚度变异性,将针头穿透过度的风险降至最低。